In order to comply with relevant continuing education standards the AST disclosure is to ensure that a speaker who is in the position of being able to control the content of the educational activity has disclosed to AST all relevant financial relationships with any commercial interest (see definitions below). Upon review, if it is decided that a conflict of interest is present due to a financial relationship you, spouse or partner may have, you will be contacted to discuss methods to resolve the conflict. Additionally, all disclosures must be revealed by a slide at the beginning of the educational activity. Failure or refusal to disclose the conflict(s) could be reason for withdrawing the invitation to speak at the AST event.
As a sponsor of continuing education for the Certified Surgical Technologist (CST) and Certified Surgical First Assistant (CSFA), AST must ensure objectivity and balance in all the continuing education (CE) activities.
Presentations must provide a balanced view of therapeutic options. If your presentation includes the use of a drug(s), the generic name of the drug must be used. Additionally, if the presentation describes the use of a drug, medical device or product that is not FDA approved or the unapproved use of a drug, medical device or product, the speaker has the responsibility for disclosing this information to the audience during the presentation.
The intent of this disclosure is not to prevent speakers/subject matter experts with a significant financial relationship from making a presentation, but rather to provide the audience with information for their own judgment.